These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 15724937)
41. Letter to editor: Late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol. Sarli B; Celik T; Kaya MG Int J Cardiol; 2013 Oct; 168(3):3134-5. PubMed ID: 23628294 [No Abstract] [Full Text] [Related]
42. Carvedilol: a new approach to antihypertensive therapy. Proceedings from International Symposium on Carvedilol. Berlin, March 14-17, 1991. Clin Investig; 1992; 70 Suppl 1():S1-131. PubMed ID: 1350477 [No Abstract] [Full Text] [Related]
43. [Clinical and hemodynamic efficiency of dilatrend treatment in patients with dilatation cardiomyopathy]. Dzhaniashvili MI; Chanturiia NG; Panchulidze GA Georgian Med News; 2005 Dec; (129):60-3. PubMed ID: 16444033 [TBL] [Abstract][Full Text] [Related]
44. Advanced practice nursing for congestive heart failure. McCormick SA Crit Care Nurs Q; 1999 Feb; 21(4):1-8. PubMed ID: 10646426 [TBL] [Abstract][Full Text] [Related]
46. Letter by Rosner et al regarding article, "When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure". Rosner GF; Garan AR; Uriel N Circulation; 2013 Jan; 127(4):e431. PubMed ID: 23357667 [No Abstract] [Full Text] [Related]
47. Images in cardiovascular medicine. Mitochondrial cardiomyopathy evaluated with cardiac magnetic resonance. Nakanishi M; Harada M; Tadamura E; Kotani H; Kawakami R; Kuwahara K; Nakagawa Y; Usami S; Kinoshita H; Fujiwara M; Hosoda K; Ueshima K; Nakao K Circulation; 2007 Jul; 116(2):e25-6. PubMed ID: 17620516 [No Abstract] [Full Text] [Related]
48. Carvedilol. A wide therapeutic potential in cardiovascular syndromes. Proceedings of a satellite symposium organized by the International Institute for Therapeutic Research (ICIT). Scheveningen, The Netherlands, August 23, 1991. Cardiology; 1993; 82 Suppl 3():1-58. PubMed ID: 8221744 [No Abstract] [Full Text] [Related]
49. [Carvedilol--2 companies introduce the same antihypertensive agent]. Thon H Tidsskr Nor Laegeforen; 1994 Jan; 114(2):200. PubMed ID: 8122205 [No Abstract] [Full Text] [Related]
50. [Carvedilol--2 companies introduce the same antihypertensive agent]. Slinning H Tidsskr Nor Laegeforen; 1994 Jan; 114(1):63. PubMed ID: 8296287 [No Abstract] [Full Text] [Related]
51. [Pharmaco-economical aspects of the treatment of patients with chronic cardiac failure in hospital]. Ostroumova OD; Shorikova EG; Mamaev VI Kardiologiia; 2004; 44(2):108-10. PubMed ID: 15125436 [No Abstract] [Full Text] [Related]
52. Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients. Marazzi G; Volterrani M; Caminiti G; Iaia L; Massaro R; Vitale C; Sposato B; Mercuro G; Rosano G J Card Fail; 2011 Sep; 17(9):703-9. PubMed ID: 21872138 [TBL] [Abstract][Full Text] [Related]